In postmenopausal female patients with T2DM, a higher GNRI value is independently associated with a lower risk of PMOP. GNRI demonstrates moderate discriminatory ability for identifying PMOP in this population and may serve as a simple and useful auxiliary indicator for assessing skeletal health risk in clinical practice, pending further prospective validation.
Haibier et al. (Mon,) studied this question.